Merck Offers to Settle Vioxx Cases for $4.85 Billion

In a reversal of sorts, Merck has offered to settle approximately 27,000 Vioxx claims for $4.85 billion. Merck has offered to settle these cases without admitting liability or fault. Vioxx was pulled from the market in September 2004 after a scientific study showed that Vioxx doubled the risk of heart attacks and strokes for patients taking Vioxx for more than 18 months.
In order to participate in the settlement, claimants will have to meet certain criteria including medical proof of a heart attack or stroke and that the patient received at least 30 Vioxx pills and took them within two weeks or less of the medical event that caused the injury.